Switching from intravenous to subcutaneous infliximab maintenance therapy in inflammatory bowel disease: Post hoc longitudinal analysis of a randomized trial
PMID: 38365502
Source: Dig Liver Dis
Publication date:
2025-07-24
Year:
2024
Abstract
NULL